US Patent No: 6,057,373

Number of patents in Portfolio can not be more than 2000

Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists

1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes a novel treatment for movement disorders, including tardive dyskinesia and tardive dystonia, and focal dystonias not due to neuroleptics, including blepharospasm, Meige syndrome, and occupational dystonias. The treatment of the present invention utilizes agents that act as NMDA-type glutamate receptor antagonists The invention also involves the use of an ion channel blocking agent to augment the therapeutic action of the drug treatments described. A particularly preferred ion channel blocking agent is magnesium.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
SYNCHRONEURON INC.LEXINGTON, MA8

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fogel, Barry S Providence, RI 24 199

Cited Art Landscape

Patent Info (Count) # Cites Year
 
CHILDREN'S MEDICAL CENTER CORPORATION (3)
5,455,279 Regimen method of mediating neuronal damage using nitroglycerine 13 1993
5,747,545 Method of preventing NMDA receptor complex-mediated Neuronal damage 8 1995
5,614,560 Method of preventing NMDA receptor-mediated neuronal damage 31 1995
 
MERZ PHARMA GMBH & CO. KGAA (2)
5,061,703 Adamantane derivatives in the prevention and treatment of cerebral ischemia 41 1990
5,382,601 Memantine-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof 31 1993
 
CENTER FOR NEUROLOGIC STUDY NOT-FOR-PROFIT RESEARCH FOUNDATION OF CALIFORNIA (1)
5,206,248 Method for reducing emotional lability 14 1992
 
LIPHA (1)
4,355,043 Novel derivatives of 3-aminopropanesulfonic acid having a reinforced activity on membrane 23 1980
 
MERZ + CO. GMBH & CO. (1)
5,262,162 Cerebral-activating extract 11 1991
 
PODUSLO, JOSEPH F. (1)
5,670,477 Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents 53 1995
 
RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. (1)
5,602,150 Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia 13 1995
 
RHONE-POULENC SURFACTANTS AND SPECIALTIES, L.P. (1)
4,233,229 Preparation of salt-free N-acyl taurines 9 1978
 
Other [Check patent profile for assignment information] (1)
5,604,198 Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents 42 1994

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
NEURONETICS, INC. (13)
7,153,256 Reducing discomfort caused by electrical stimulation 20 2003
7,614,996 Reducing discomfort caused by electrical stimulation 1 2003
7,320,664 Reducing discomfort caused by electrical stimulation 9 2004
6,926,660 Facilitating treatment via magnetic stimulation 18 2004
7,601,115 Seizure therapy method and apparatus 2 2004
7,824,324 Magnetic core for medical procedures 1 2005
7,963,903 Magnetic core for medical procedures 0 2005
8,118,722 Reducing discomfort caused by electrical stimulation 0 2005
7,560,058 Magnetic core for medical procedures 3 2006
8,506,468 Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators 0 2008
8,657,731 Magnetic core for medical procedures 0 2009
8,246,529 Magnetic core for medical procedures 1 2010
8,517,908 Reducing discomfort caused by electrical stimulation 0 2012
 
ENDO PHARMACEUTICALS INC. (2)
6,187,338 Anticonvulsant containing composition for treating neuropathic pain 51 1999
6,406,716 Anticonvulsant containing composition for treating neuropathic pain 6 2001
 
FOREST LABORATORIES HOLDINGS LIMITED (2)
7,456,224 Method for treating autism 3 2004
8,834,924 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane 0 2011
 
BHI LIMITED PARTNERSHIP (1)
8,748,656 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid 0 2007
 
EMORY UNIVERSITY (1)
7,375,136 pH-dependent NMDA receptor antagonists 1 2002
 
KANGWON NATIONAL UNIVERSITY UNIVERSITY-INDUSTRY COOPERATION FOUNDATION (1)
7,691,874 Neuroprotective properties of dextrorotatory morphinans 0 2005
 
NEUROP, INC. (1)
8,420,680 NMDA receptor antagonists for neuroprotection 0 2008
 
Nueronetics, Inc. (1)
7,857,746 System and method to reduce discomfort using nerve stimulation 2 2004
 
Warner-Lambert Company (1)
6,942,876 Analgesic compositions comprising anti-epileptic compounds and methods of using same 5 2002
 
YALE UNIVERSITY (1)
8,778,979 Glutamate agents in the treatment of mental disorders 0 2006